Literature DB >> 19054914

Enterovirus 71 in Taiwan.

Luan-Yin Chang1.   

Abstract

The enterovirus 71 (EV71) outbreak in Taiwan in 1998 proved fatal in many children. A seroepidemiological study performed prior to the 1998 outbreak showed pre-epidemic (1997) EV71 seroprevalence rates to be about 60-70% in adults and children older than 6 years of age. A retrospective case review carried out from 1980-81 identified 16 cases of hand, foot and mouth disease associated with central nervous system involvement, two of whom died soon after hospitalization. There were 405 severe cases and 78 deaths reported in the 1998 epidemic, and dozens of fatal EV71 cases were still reported from 2000 to 2002. A stage-based management strategy was developed to reduce fatality, but most survivors of brainstem encephalitis with cardiopulmonary failure have neurologic sequelae and impaired cognition. Continuous clinical and laboratory surveillance of EV71 disease is required to enable earlier implementation of control and prevention measures. Development of EV71-specific antiviral therapy, a novel class of imidazolidinones, and development of a vaccine are ongoing.

Entities:  

Mesh:

Year:  2008        PMID: 19054914     DOI: 10.1016/S1875-9572(08)60023-6

Source DB:  PubMed          Journal:  Pediatr Neonatol        ISSN: 1875-9572            Impact factor:   2.083


  50 in total

1.  Antibodies to P-selectin glycoprotein ligand-1 block dendritic cell-mediated enterovirus 71 transmission and prevent virus-induced cells death.

Authors:  Xiao-Xin Ren; Chuan Li; Si-Dong Xiong; Zhong Huang; Jian-Hua Wang; Hai-Bo Wang
Journal:  Virulence       Date:  2015-09-23       Impact factor: 5.882

Review 2.  How to understand the efficacy measurements for enterovirus type 71 vaccine?

Authors:  Jing-Xin Li; Fan-Yue Meng; Zheng-Lun Liang; Qun-Ying Mao; Feng-Cai Zhu
Journal:  Hum Vaccin Immunother       Date:  2013-11-26       Impact factor: 3.452

3.  Smartphone applications (apps) for heart rate measurement in children: comparison with electrocardiography monitor.

Authors:  Chi-Lin Ho; Yun-Ching Fu; Ming-Chih Lin; Sheng-Ching Chan; Betau Hwang; Sheng-Ling Jan
Journal:  Pediatr Cardiol       Date:  2013-11-21       Impact factor: 1.655

Review 4.  Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy.

Authors:  S Aswathyraj; G Arunkumar; E K Alidjinou; D Hober
Journal:  Med Microbiol Immunol       Date:  2016-07-12       Impact factor: 3.402

5.  Type I Interferons Triggered through the Toll-Like Receptor 3-TRIF Pathway Control Coxsackievirus A16 Infection in Young Mice.

Authors:  Juhao Yang; Chunfu Yang; Nining Guo; Kai Zhu; Kaiming Luo; Na Zhang; Hui Zhao; Ying Cui; Lei Chen; Hongyang Wang; Jun Gu; Baoxue Ge; Cheng-Feng Qin; Qibin Leng
Journal:  J Virol       Date:  2015-08-19       Impact factor: 5.103

6.  Identification of specific antigenic epitope at N-terminal segment of enterovirus 71 (EV-71) VP1 protein and characterization of its use in recombinant form for early diagnosis of EV-71 infection.

Authors:  Jianhua Zhang; Bingfu Jiang; Mingjie Xu; Xing Dai; Michael A Purdy; Jihong Meng
Journal:  Virus Res       Date:  2014-06-19       Impact factor: 3.303

7.  Development and evaluation of a reverse transcription-loop-mediated isothermal amplification assay for rapid detection of enterovirus 71.

Authors:  Tao Jiang; Juan Liu; Yong-Qiang Deng; Li-Juan Xu; Xiao-Feng Li; Jian-Feng Han; Rui-Yuan Cao; E-De Qin; Cheng-Feng Qin
Journal:  J Clin Microbiol       Date:  2010-12-22       Impact factor: 5.948

8.  Epidemiology of enterovirus 71 in the Netherlands, 1963 to 2008.

Authors:  Sabine van der Sanden; Marion Koopmans; Gökhan Uslu; Harrie van der Avoort
Journal:  J Clin Microbiol       Date:  2009-07-22       Impact factor: 5.948

Review 9.  Coxsackievirus A16: epidemiology, diagnosis, and vaccine.

Authors:  Qunying Mao; Yiping Wang; Xin Yao; Lianlian Bian; Xing Wu; Miao Xu; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2013-11-14       Impact factor: 3.452

10.  Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells.

Authors:  Betsy Yang; Hau Chuang; Kuender D Yang
Journal:  Virol J       Date:  2009-09-15       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.